A detailed history of Xtx Topco LTD transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 14,103 shares of ETON stock, worth $46,398. This represents 0.01% of its overall portfolio holdings.

Number of Shares
14,103
Previous 22,858 38.3%
Holding current value
$46,398
Previous $100,000 48.0%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$3.48 - $5.03 $30,467 - $44,037
-8,755 Reduced 38.3%
14,103 $52,000
Q4 2023

Feb 13, 2024

BUY
$3.45 - $4.66 $37,756 - $50,999
10,944 Added 91.86%
22,858 $100,000
Q3 2023

Nov 13, 2023

BUY
$2.55 - $5.63 $30,380 - $67,075
11,914 New
11,914 $49,000
Q4 2021

Feb 11, 2022

SELL
$3.66 - $6.59 $53,626 - $96,556
-14,652 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$4.2 - $6.26 $168 - $250
-40 Reduced 0.27%
14,652 $74,000
Q2 2021

Aug 12, 2021

BUY
$5.71 - $8.85 $83,891 - $130,024
14,692 New
14,692 $91,000

Others Institutions Holding ETON

About Eton Pharmaceuticals, Inc.


  • Ticker ETON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,297,000
  • Market Cap $83.2M
  • Description
  • Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...
More about ETON
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.